Alcohol
Volume 37, Issue 1 , Pages 35-45 , August 2005

Discriminative stimulus effects of 5.6mg/kg pregnanolone in DBA/2J and C57BL/6J inbred mice

  • Erin E. Shannon

      Affiliations

    • Department of Physiology and Pharmacology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1083, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-336-713-7157; fax: +1-336-713-7168.
  • ,
  • Robert H. Purdy

      Affiliations

    • Veterans Medical Research Foundation and the Department of Veterans Affairs Medical Center, San Diego, CA 92161, USA
    • Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037, USA
  • ,
  • Kathleen A. Grant

      Affiliations

    • Department of Physiology and Pharmacology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1083, USA

Received 11 July 2005 ,Revised 17 October 2005 ,Accepted 18 October 2005.

References 

  1. Ator NA, Grant KA, Purdy RH, Paul SM, Griffiths RR. Drug discrimination analysis of endogenous neuroactive steroids in rats. Eur J Pharmacol. 1993;241:237–243
  2. Bienkowski P, Kostowski W. Discriminative stimulus properties of ethanol in the rat: effects of neurosteroids and picrotoxin. Brain Res. 1997;753:348–352
  3. Bowen CA, Gatto GJ, Grant KA. Assessment of the multiple discriminative stimulus effects of ethanol using an ethanol–pentobarbital–water discrimination in rats. Behav Pharmacol. 1997;8:339–352
  4. Bowen CA, Grant KA. Increased specificity of ethanol's discriminative stimulus effects in an ethanol–pentobarbital–water discrimination in rats. Drug Alcohol Depend. 1999;55:13–24
  5. Engel SR, Purdy RH, Grant KA. Characterization of discriminative stimulus effects of the neuroactive steroid pregnanolone. J Pharmacol Exp Ther. 2001;297:489–495
  6. Faure-Halley C, Graham D, Aribilla S, Langer S. Expression and properties of recombinant α1β2γ2 and α5β2γ2 forms of the GABAA receptor. Eur J Pharmacol Mol Pharmacol Sect. 1993;246:283–287
  7. Grant KA, Engel SR. Neurosteroids and behavior. In:  Biggio G,  Purdy RH editor. Neurosteroids and Brain Function. San Diego, CA: Academic Press; 2001;p. 321–342
  8. Holtzman SG. Discriminative stimulus effects of drugs: relationship to potential for abuse. In:  Adler MW,  Cowan A editor. Modern Methods in Pharmacology, Testing and Evaluation of Drugs of Abuse. New York: Wiley-Liss; 1990;p. 193–210
  9. Gulinello M, Gong QH, Li X, Smith SS. Short-term exposure to a neuroactive steroid increases α4 GABAA receptor subunit levels in association with increased anxiety. Brain Res. 2001;910:55–66
  10. Koek W, Kleven MS, Colpaert FC. Effects of the NMDA antagonist, dizocilipine, in various drug discriminations: characterization of intermediate levels of drug lever selection. Behav Pharmacol. 1995;6:590–600
  11. Lambert JJ, Belelli D, Hill-Vening C, Peters JA. Neurosteroids and GABAA receptor function. Trends Pharmacol Sci. 1995;16:295–303
  12. Morrow AL, VanDoren MJ, Penland SN, Matthews DB. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Brain Rev. 2001;37:98–109
  13. Park-Chung M, Wu F-S, Farb DH. 3α-Hydroxy-5β-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol Pharmacol. 1994;46:146–150
  14. Platt DM, Duggan A, Spealman RD, Cook JM, Li X, Yin W, et al. Contribution of α1GABAA and α5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys. J Pharmacol Exp Ther. 2005;313:658–667
  15. Prince RJ, Simmonds MA. 5β-Pregnan-3β-ol-20-one, a specific antagonist at the neurosteroid site of the GABAA receptor complex. Neurosci Lett. 1992;135:273–275
  16. Prince RJ, Simmonds MA. Differential antagonism by epipregnanolone of alphaxalone and pregnanolone potentiation of the [3H] flunitrazepam binding suggests more than one class of binding site for steroids at GABAA receptors. Neuropharmacology. 1993;32:59–63
  17. Pritchett DB, Seeburg PH. γ-Aminobutyric acidA receptor α5-subunit creates novel type II benzodiazepine receptor pharmacology. J Neurochem. 1990;54:1802–1804
  18. Purdy RH, Morrow AL, Blinn JR, Paul SM. Synthesis, metabolism, and pharmacological activity of 3α-hydroxy steroids which potentiate GABAA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J Med Chem. 1990;33:1572–1581
  19. Shannon EE, Porcu P, Purdy RH, Grant KA. Characterization of the discriminative stimulus effects of neuroactive steroid pregnanolone in DBA/2J and C57BL/6J inbred mice. J Pharmacol Exp Ther. 2005;314:675–685
  20. Shelton KL, Grant KA. Discriminative stimulus effects of ethanol in C57BL/6J and DBA/2J inbred mice. Alcohol Clin Exp Res. 2002;26:747–757
  21. VanDoren MJ, Matthews DB, Janis GC, Grobin AC, Devaud LL, Morrow AL. Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J Neurosci. 2000;20:1982–1989
  22. Vanover KE. Discriminative stimulus effects of the endogenous neuroactive steroid pregnanolone. Eur J Pharmacol. 1997;327:97–101

PII: S0741-8329(05)00199-0

doi: 10.1016/j.alcohol.2005.11.001

Alcohol
Volume 37, Issue 1 , Pages 35-45 , August 2005